ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona

BN

Brazilian National Cancer Institute (INCA) at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Brazilian National Cancer Institute (INCA) takes part in 7 sessions at ESMO 2026 in Madrid. Its work spans breast, ovarian and endometrial cancers, as well as cancer care and policy. It assesses evidence on breast cancer treatments and whether progression-free survival can stand in for overall survival in ovarian cancer trials.

OrganizationESMO 2026 Attendance
BN
Brazilian National Cancer Institute (INCA)
Rio de Janeiro, Brazil
Cancer centre & hospital
Federal cancer institute of Brazil's health ministry in Rio de Janeiro, running cancer hospitals, research and national cancer control policy.
Poster
Fri Oct 23
13:00–15:00
Poster
Fri Oct 23
13:00–15:00
Unplanned hospitalizations among treatment-naive breast cancer patients
ePoster session 1
Breast cancer
Chair
Sat Oct 24
14:45–16:15
Rapid oral: Policy
with Mahatma Gandhi Medical College and Hospital, World Health Organization
Abstract
Sat Oct 24
14:55–15:05
Invited Discussant 3316RO and 3317RO
Rapid oral: Policy
Poster
Sun Oct 25
12:00–12:45
Synthetic harmonization of non-exchangeable leiomyosarcoma cohorts creates comparable cross-trial anchors
Sunday Poster Display session 1
Sarcoma, CNS, head & neck and rare cancers

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Brazilian National Cancer Institute (INCA)

Tell us what you sell and we’ll find the people at Brazilian National Cancer Institute (INCA) most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction